Domain Not Resolving

Pound Sterling

Amazon Route 53

Squarespace Hosted

Business Management

Birgit Zech

Sakae Asanuma

Karin Kleinhans

Mathieu Bollen

Nicholas Tonks

Debora Dumont

Therese Liechtenstein

Claus Schalper

Simone Botti

Co-Founder, Chief Executive Officer

Edward Holson

Chief Scientific Officer and President US

Gerhard Müller

Co-Founder, Chief Scientific Officer

Europe, Middle East, and Africa (EMEA) Seed Stage Companies With Fewer Than 50 Employees (Top 10K)

Europe, Middle East, and Africa (EMEA) Startups (Top 10K)

Europe Companies With Fewer Than 1000 Employees (Top 10K)

The Netherlands Biotechnology Companies

Anavo Therapeutics is the first company to systematically drug phosphatases, a rich target space previously considered undruggable for decades. We have attracted world-leading scientific expertise in phosphatase-driven disease biology and drug discovery to unlock the full potential of phosphatase-targeted allosteric modulators. In oncology, Anavo is developing multiple first-in-class therapeutic programs and will build on partnerships around its platform to establish a rich pipeline across several indications

Seed Round - Anavo Therapeutics

Bioqube Ventures

Inkef

M Ventures

Taiho Ventures

Leiden

Zuid-Holland

The Netherlands

Europe

Anavo Therapeutics

Anavo Therapeutics Appoints Dr. Edward Holson as Chief Scientific Officer and President US

Anavo Therapeutics Strengthens Management Team

Anavo Therapeutics Raises €8.5M; Extends Seed Round to €28M

Anavo Therapeutics extends Seed Round to EUR 28 Million to Advance Pipeline of Novel Phosphatase Modulators Toward the Clinic

Anavo Therapeutics–McDermott C: board, 202112– Board Chairman main org Primmune Therapeutics Inc

Anavo Therapeutics–Bioqube Ventures: investment, 202104 seed financing round totalling €20m incl co-investor Bioqube Ventures

Anavo Therapeutics–MacDougall Advisors: public relations, 202104 service existent by MacDougall

Anavo Therapeutics wants Big Pharma to dust off the shelves in search of phosphatase drugs

Anavo Therapeutics closes $24M seed round to drug the phosphatome

United States

North America

Latvia

Palestinian Territory

Asia

Anavo Therapeutics is a global leader in unlocking the full therapeutic potential of human phosphatase biology. The company focuses on systematic drug discovery and development approaches aimed at phosphatases, a rich and largely untapped therapeutic target class.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	Mar 8, 2024 11:57 AM	cd77cc05
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Mar 8, 2024 11:57 AM	1015c57c
company summary	general
signals	general
crunchbase trigger	general	Oct 31, 2024 9:55 AM	033ac299
crunchbase profile	general	Oct 31, 2024 10:49 AM	7a7cacaf
li profile	general
translate crunchbase fundingrounds	general	Nov 6, 2024 3:12 PM	9afc9b20
peers	general
news basic	general	Mar 8, 2024 11:57 AM	22fa0246
bundesanzeiger	filings
financials download nd	financials
private financials	financials

ANAV

COM:ANAVOTX

Anavo Therapeutics